[1]CurrentPatentAssignee:PFIZERINC-US4940710,1990,A
[1]Patent:WO2019/115660,2019,A1.Locationinpatent:Page/Pagecolumn42;51-52
2866308-30-5
1190105-66-8 | 2-Pyrrolidinyl-3-acetyl Desmorpholinylrocuronium Bromide | AA008VS1
113835-76-0 | Olopatadine Methanol | AA008W12 | MFCD27978127
1190043-34-5 | Lercanidipine-d3 | AA008W8X
1134639-23-8 | (1E,4Z,6E)-1,7-Bis[4-[[(1,1-diMethylethyl)diMethylsilyl]oxy]-3-Methoxyphenyl]-5-hydroxy-1,4,6-heptatrien-3-one | AA008WK9 | MFCD28138384
103775-14-0 | MOEXIPRILAT HYDRATE | AA008WRU | MFCD08063675
117657-38-2 | 1H-PYRROLE-1-CARBOXYLIC ACID, 2,5-DIBROMO-, 1,1-DIMETHYLETHYL ESTER | AA008WZD | MFCD11112105
115966-68-2 | Histatin 5 | AA008X8J
1175036-51-7 | 1-(4-Hydroxyphenyl)piperazine hydrochloride | AA008XKJ | MFCD08059228
1149804-35-2 | 4,4,5,5-Tetramethyl-2-[10-(1-naphthyl)anthracen-9-yl]-1,3,2-dioxaborolane | AA008XY9 | MFCD30470497
108310-79-8 | Thiazolo[5,4-c]pyridin-2-amine | AA008YC5 | MFCD09909658